LLY

736.61

+0.51%↑

JNJ

177.74

-0.07%↓

ABBV

211.72

+0.02%↑

UNH

307.43

-0.44%↓

NVO

56.76

+0.71%↑

LLY

736.61

+0.51%↑

JNJ

177.74

-0.07%↓

ABBV

211.72

+0.02%↑

UNH

307.43

-0.44%↓

NVO

56.76

+0.71%↑

LLY

736.61

+0.51%↑

JNJ

177.74

-0.07%↓

ABBV

211.72

+0.02%↑

UNH

307.43

-0.44%↓

NVO

56.76

+0.71%↑

LLY

736.61

+0.51%↑

JNJ

177.74

-0.07%↓

ABBV

211.72

+0.02%↑

UNH

307.43

-0.44%↓

NVO

56.76

+0.71%↑

LLY

736.61

+0.51%↑

JNJ

177.74

-0.07%↓

ABBV

211.72

+0.02%↑

UNH

307.43

-0.44%↓

NVO

56.76

+0.71%↑

Search

Omnicell Inc

Open

BrancheGesundheitswesen

32.77 2.34

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

32.02

Max

32.79

Schlüsselkennzahlen

By Trading Economics

Einkommen

13M

5.6M

Verkäufe

21M

291M

KGV

Branchendurchschnitt

66.18

35.724

EPS

-0.151

Gewinnspanne

1.941

Angestellte

3,650

EBITDA

42M

30M

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

+30.06% upside

Dividenden

By Dow Jones

Nächstes Ergebnis

29. Okt. 2025

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

162M

1.5B

Vorheriger Eröffnungskurs

30.43

Vorheriger Schlusskurs

32.77

Nachrichtenstimmung

By Acuity

50%

50%

167 / 371 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Strong Bearish Evidence

Omnicell Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

2. Sept. 2025, 23:07 UTC

Akquisitionen, Fusionen, Übernahmen

Broadwood Partners Plans to Vote Against Staar Sale to Alcon

2. Sept. 2025, 22:10 UTC

Wichtige Markttreiber

Bruker Shares Fall on Convertible Share Offering Aimed at Debt Repayment

2. Sept. 2025, 21:47 UTC

Ergebnisse

Alimentation Couche-Tard Logs Lower Profit, Revenue in 1Q

2. Sept. 2025, 16:52 UTC

Wichtige Markttreiber

CleanCore Solutions Shares Drop After $175 Million Private Investment

2. Sept. 2025, 22:47 UTC

Market Talk

Google, Apple Can Grow AI Deal With Lawsuit Resolved -- Market Talk

2. Sept. 2025, 21:40 UTC

Akquisitionen, Fusionen, Übernahmen

Investors Have to Be Ready for State Capitalism. What Areas to Watch. -- Barrons.com

2. Sept. 2025, 21:07 UTC

Ergebnisse

Couche-Tard 1Q U.S. Same-Store Merchandise Revenue Up 0.4% >ATD.T

2. Sept. 2025, 21:07 UTC

Ergebnisse

Couche-Tard 1Q Canada Same-Store Merchandise Revenue Up 4.1% >ATD.T

2. Sept. 2025, 21:05 UTC

Ergebnisse

Couche-Tard 1Q Rev $17.35B >ATD.T

2. Sept. 2025, 21:05 UTC

Ergebnisse

Couche-Tard 1Q Adj EPS 78c >ATD.T

2. Sept. 2025, 21:05 UTC

Ergebnisse

Couche-Tard 1Q EPS 82c >ATD.T

2. Sept. 2025, 21:05 UTC

Ergebnisse

Couche-Tard 1Q Net $782.5M >ATD.T

2. Sept. 2025, 21:00 UTC

Market Talk

ESG Roundup: Market Talk

2. Sept. 2025, 20:53 UTC

Market Talk
Akquisitionen, Fusionen, Übernahmen

Knight-Swift Transportation Endorses Union Pacific, Norfolk Southern Merger -- Market Talk

2. Sept. 2025, 20:51 UTC

Akquisitionen, Fusionen, Übernahmen

Buffett Dislikes Breakup of Kraft Heinz. It's Been One of His Worst Investments. -- Barrons.com

2. Sept. 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

2. Sept. 2025, 20:27 UTC

Ergebnisse

NIO Stock Rises After Second-Quarter Loss Narrows -- Barrons.com

2. Sept. 2025, 20:24 UTC

Akquisitionen, Fusionen, Übernahmen

Air Lease Is Going Private. Why Boeing Stock Is Up. -- Barrons.com

2. Sept. 2025, 20:18 UTC

Akquisitionen, Fusionen, Übernahmen

Procter & Gamble Does Not Endorse Tutanota's Unsolicited Mini-Tender Offer >PG

2. Sept. 2025, 20:17 UTC

Akquisitionen, Fusionen, Übernahmen

Procter & Gamble: Tutanota Says It Expects to Extend Offer for Successive Periods of Up to 180 Days Until Market Price Exceeds Offer Price >PG

2. Sept. 2025, 20:16 UTC

Akquisitionen, Fusionen, Übernahmen

Procter & Gamble: 'Shareholders Who Tender Their Shrs in the Offer Will Receive a Below-Market Price' >PG

2. Sept. 2025, 20:16 UTC

Akquisitionen, Fusionen, Übernahmen

Procter & Gamble: Offer by Tutanota Is to Purchase Up to 500,000 Shrs at $128 Each

2. Sept. 2025, 20:15 UTC

Akquisitionen, Fusionen, Übernahmen

Procter & Gamble Has Been Notified of Unsolicited Mini-Tender Offer by Tutanota >PG

2. Sept. 2025, 19:55 UTC

Ergebnisse

GM Had a Record Month of EV Sales. A 'Collapse' Is Coming. -- Barrons.com

2. Sept. 2025, 19:50 UTC

Akquisitionen, Fusionen, Übernahmen

Food Giants Are Struggling. Could Mergers, Spinoffs, and Activist Stakes Help? -- Barrons.com

2. Sept. 2025, 19:09 UTC

Market Talk

Oil Futures Gain on Geopolitical Premium -- Market Talk

2. Sept. 2025, 19:00 UTC

Market Talk

U.S. Natural Gas Futures Recover $3 Level -- Market Talk

2. Sept. 2025, 18:12 UTC

Market Talk

Gold Pushes To New Record -- Market Talk

2. Sept. 2025, 17:04 UTC

Market Talk

Philip Morris Riding Smoke-Free Products to Higher Margins -- Market Talk

2. Sept. 2025, 16:57 UTC

Akquisitionen, Fusionen, Übernahmen

Air Lease Is Going Private. Why Boeing Stock Is Up. -- Barrons.com

Peer-Vergleich

Kursveränderung

Omnicell Inc Prognose

Kursziel

By TipRanks

30.06% Vorteil

12-Monats-Prognose

Durchschnitt 41.75 USD  30.06%

Hoch 55 USD

Tief 32 USD

Basierend auf 6 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Omnicell Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

6 ratings

4

Buy

2

Halten

0

Sell

Technischer Score

By Trading Central

24.23 / 30.44Unterstützung & Widerstand

Kurzfristig

Strong Bearish Evidence

Mittelfristig

Strong Bearish Evidence

Langfristig

Bearish Evidence

Stimmung

By Acuity

167 / 371 Ranking in Gesundheitswesen

Nachrichtenstimmung

Neutral

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Omnicell Inc

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots; and inventory management software. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.